心房颤动合并急性冠状动脉综合征患者冠状动脉介入治疗术后抗栓药物应用

摘要

心房颤动是心血管内科常见病之一,其发病率与年龄有一定相关性,随着人口老龄化的进程,心房颤动的发生率亦逐年递增.心房颤动患者自身多存在血栓或出血倾向,具有较高的致残及致死率.随着临床研究的不断深入与细化,接受冠状动脉介入治疗的患者中心房颤动患者占有较高比例.因此,针对心房颤动并接受冠状动脉支架治疗的患者如何进行出血与栓塞风险的评估,权衡利弊,规范化、个体化、精准地选择抗栓药物,是心血管内科临床研究的热点.%Atrial fibrillation is one of the common diseases of cardiovascular medicine,the incidence and age of which have a certain relevance,and with the aging process of population, the incidence of atrial fibrillation is increasing year by year.There is a significant thromboembolism and bleeding tendency in patients with atrial fibrillation,so these patients often have a higher morbidity and mortality rate.With the deepening and refinement of the clinical research,there is a higher pro-portion of patients receiving coronary artery intervention among patients with atrial fibrillation.Therefore,for patients with atrial fibrillation receiving coronary artery stent treatment,how to assess the risk of bleeding and embolism,weigh the pros and cons,standardized,individual,accurate selection of antithrombotic drugs,are the hot spots of the clinical research of cardiovascular medicine.